Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 1 (2), 187-217

Overview of Medically Important Antifungal Azole Derivatives

Affiliations
Review

Overview of Medically Important Antifungal Azole Derivatives

R A Fromtling. Clin Microbiol Rev.

Abstract

Fungal infections are a major burden to the health and welfare of modern humans. They range from simply cosmetic, non-life-threatening skin infections to severe, systemic infections that may lead to significant debilitation or death. The selection of chemotherapeutic agents useful for the treatment of fungal infections is small. In this overview, a major chemical group with antifungal activity, the azole derivatives, is examined. Included are historical and state of the art information on the in vitro activity, experimental in vivo activity, mode of action, pharmacokinetics, clinical studies, and uses and adverse reactions of imidazoles currently marketed (clotrimazole, miconazole, econazole, ketoconazole, bifonazole, butoconazole, croconazole, fenticonazole, isoconazole, oxiconazole, sulconazole, and tioconazole) and under development (aliconazole and omoconazole), as well as triazoles currently marketed (terconazole) and under development (fluconazole, itraconazole, vibunazole, alteconazole, and ICI 195,739).

Similar articles

See all similar articles

Cited by 75 articles

See all "Cited by" articles

References

    1. Gynakol Rundsch. 1983;23 Suppl 1:12-9 - PubMed
    1. Mycopathologia. 1985 Sep;91(3):151-7 - PubMed
    1. Chemotherapy. 1976;22(3-4):211-20 - PubMed
    1. Am J Med. 1987 Mar 23;82(3 Spec No):676-80 - PubMed
    1. Ann Intern Med. 1983 Jan;98(1):13-20 - PubMed

LinkOut - more resources

Feedback